Pay in 4 interest-free payments of $6.90 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Wang X, Chi D, Song D, Su G, Li L, Shao L
doi: 10.3389/fimmu.2025.1610368 Received 11 April 2025 Accepted 26 June 2025 Published 15 July 2025 Volume 16 - 2025 Edited by Li-Tung Huang, Kaohsiung Chang Gung Memorial Hospital, Taiwan Reviewed by Beata Kasztelan-Szczerbinska, Medical University of Lublin, Poland Edit Posta, University of Debrecen, Hungary Updates Copyright 2025 Migliorisi, Gabbiadini, Dal Buono, Ferraris, Privitera, Petronio, Bertoli, Bezzio and Armuzzi
Recent Findings Emerging evidence suggests that GLP-1R agonists have a role in pediatric obesity treatment
The latest trend in peptide therapy combines tirzepatide with niacinamide, promising a more supported and effective journey
References Yasui T, Okada A, Hamamoto S, Ando R, Taguchi K, Tozawa K et al (2017) Pathophysiology-based treatment of urolithiasis
US$ 27.42
US$ 26.08
US$ 28.17
US$ 24.34
US$ 25.26
US$ 21.77
US$ 29.73
